ANTI-AGING EFFICACY AND SAFETY OF GLYCOSIDES-BASED STANDARDIZED FENUGREEK SEED EXTRACT SUPPLEMENTATION IN HEALTHY AGING ADULTS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
DOI:
https://doi.org/10.22159/ijpps.2026v18i5.57976Keywords:
Anti-aging, Fatigue, Fenugreek seed, Glycosides, Nad, Quality of lifeAbstract
Objective: The efficacy and safety evaluation of oral “glycosides-based standardized fenugreek seed extract" (SFSE-G) supplementation to a healthy aging adult population.
Methods: A total of 112 healthy individuals aged ≥ 45 years (determined by chronological age and Levine’s phenotypic age) were randomized using a computer-generated list (1:1 ratio) to receive 300 mg capsules of either SFSE-G or placebo daily for 12 weeks in a double-blind design. The outcome measures were changes in plasma “nicotinamide adenine dinucleotide” (NAD⁺) levels, plasma “adenosine triphosphate” (ATP) levels, phenotypic age, physical performance, fatigue, and quality of life, along with safety and tolerability.
Results: Out of 112 participants enrolled, 103 completed the study (SFSE-G: 50; placebo: 53). Plasma NAD+ concentrations were significantly (P < 0.05) higher when age correlated in SFSE-G-treated groups (vs. placebo). No serious adverse events or safety concerns were reported, indicating good tolerability of treatments. In addition, the study found that 12 weeks of 300 mg SFSE-G oral supplementation significantly (P < 0.05) increased ATP levels, improved physical fatigue, and showed trends in reducing phenotypic age and improving quality of life in correlation with age.
Conclusion: SFSE-G supplementation showed potential to mitigate age-related declines in energy metabolism and physical fatigue, with a robust safety profile.
Downloads
References
1. WHO. Global health estimates: life expectancy and leading causes of death and disability. Geneva: World Health Organization; 2021.
2. Bhattacharjee N, Schumacher A, Aali A, Habtegiorgis Y, Muthu S, Ghasemi M, et al. Supplementary appendix 1: methods appendix to" Global fertility in 204 countries and territories, 1950-2021 with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021". The Lancet. 2024;403(10440):2057–99. doi: 10.1016/S0140-6736(24)00550-6.
3. Campisi J, Kapahi P, Lithgow GJ, Melov S, Newman JC, Verdin E. From discoveries in ageing research to therapeutics for healthy ageing. Nature. 2019;571(7764):183–92. doi: 10.1038/s41586-019-1365-2, PMID: 31292558.
4. Rudnicka E, Napierała P, Podfigurna A, Męczekalski B, Smolarczyk R, Grymowicz M. The World Health Organization (WHO) approach to healthy ageing. Maturitas. 2020;139:6–11. doi: 10.1016/j.maturitas.2020.05.018.
5. Roman MA, Rossiter HB, Casaburi R. Exercise, ageing and the lung. Eur Respir J. 2016;48(5):1471–86. doi: 10.1183/13993003.00347-2016, PMID: 27799391.
6. Tiwari SN, Baheti TC, C. S R, Sharma RK. Anti-aging drugs: A comprehensive pharmacological analysis. Int J Curr Pharm Res. 2025;17(5):75–6. doi: 10.22159/ijcpr.2025v17i5.7047.
7. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD(+) metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119–41. doi: 10.1038/s41580-020-00313-x, PMID: 33353981.
8. Tarragó MG, Chini CC, Kanamori KS, Warner GM, Caride A, de Oliveira GC, et al. A potent and specific CD38 inhibitor ameliorates age-related metabolic dysfunction by reversing tissue NAD+ decline. Cell Metab. 2018;27(5):1081–95. doi: 10.1016/j.cmet.2018.03.016.
9. Wagner S, Manickam R, Brotto M, Tipparaju SM. NAD(+) centric mechanisms and molecular determinants of skeletal muscle disease and aging. Mol Cell Biochem. 2022;477(6):1829–48. doi: 10.1007/s11010-022-04408-1.
10. Aman Y, Qiu Y, Tao J, Fang EF. Therapeutic potential of boosting NAD+ in aging and age-related diseases. Transl Med Aging. 2018;2:30–7. doi: 10.1016/j.tma.2018.08.003.
11. Shade C. The science behind NMN–A stable, reliable NAD+ activator and anti-aging molecule. Integr Med (Encinitas). 2020;19(1):12. PMID: 32549859.
12. Huang H. A multicentre, randomized, double blind, parallel design, placebo controlled study to evaluate the efficacy and safety of uthever (NMN supplement), an orally administered supplementation in middle aged and older adults. Front Aging. 2022:26. doi: 10.3389/fragi.2022.851698, PMID: 35821806.
13. Mills KF, Yoshida S, Stein LR, Grozio A, Kubota S, Sasaki Y, et al. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell Metab. 2016;24(6):795–806. doi: 10.1016/j.cmet.2016.09.013.
14. Irie J, Inagaki E, Fujita M, Nakaya H, Mitsuishi M, Yamaguchi S, et al. Effect of Oral Administration of Nicotinamide Mononucleotide on Clinical Parameters and Nicotinamide Metabolite Levels in Healthy Japanese Men. Endocr J. 2020;67(2):153–60. doi: 10.1507/endocrj.ej19-0313.
15. Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9(1):9772. doi: 10.1038/s41598-019-46120-z, PMID: 31278280.
16. Boo YC. P-Coumaric Acid as an Active Ingredient in Cosmetics: A Review Focusing on Its Antimelanogenic Effects. Antioxidants. 2019;8(8):275. doi: 10.3390/antiox8080275.
17. Youssef FS, Ramadan MF, Echeverria Moran V, Aremu AO, Mamadalieva NZ. Editorial: Potential of natural products as drug leads possessing antioxidant and anti-aging properties. Front Pharmacol. 2022;13:1094950. doi: 10.3389/fphar.2022.1094950, PMID: 36569304.
18. Hozzein WN, Saleh AM, Habeeb TH, Wadaan MA, AbdElgawad H. CO2 treatment improves the hypocholesterolemic and antioxidant properties of fenugreek seeds. Food Chem. 2020;308:125661. doi: 10.1016/j.foodchem.2019.125661.
19. Thakurdesai PA, Deshpande PO, Pore MP. Characterization, preclinical efficacy and toxicity evaluations of flavonoids glycosides based standardized fenugreek seed extract (FEFLG). Pharmacogn J. 2023;15(1):90–105. doi: 10.5530/pj.2023.15.13.
20. Kandhare AD, Bodhankar SL, Mohan V, Thakurdesai PA. Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β. Chem Biol Interact. 2015;237:151–65. doi: 10.1016/j.cbi.2015.06.019.
21. Deshpande P, Mohan V, Thakurdesai P. Preclinical safety assessment of glycosides based standardized fenugreek seeds extract: Acute, subchronic toxicity and mutagenicity studies. J Appl Pharm Sci. 2016;6(9):179–88. doi: 10.7324/JAPS.2016.60927.
22. Mathur R, Swaminathan S. National ethical guidelines for biomedical & health research involving human participants, 2017: A commentary. Indian J Med Res. 2018;148(3):279–83. doi: 10.4103/0971-5916.245303, PMID: 30425217.
23. Shrestha B, Dunn L. The declaration of Helsinki on medical research involving human subjects: a review of seventh revision. J Nepal Health Res Counc. 2019;17(04):548–52. doi: 10.33314/jnhrc.v17i4.1042, PMID: 32001865.
24. Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging. 2018;10(4):573. doi: 10.18632/aging.101414, PMID: 29676998.
25. Dellinger RW, Santos SR, Morris M, Evans M, Alminana D, Guarente L, et al. Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study. NPJ Aging Mech Dis. 2017;3(1):1–9. doi: 10.1038/s41514-017-0016-9, PMID: 29184669.
26. Harada ND, Chiu V, Stewart AL. Mobility-related function in older adults: assessment with a 6-minute walk test. Arch Phys Med Rehabil. 1999;80(7):837–41. doi: 10.1016/s0003-9993(99)90236-8.
27. Rikli RE, Jones CJ. The reliability and validity of a 6-minute walk test as a measure of physical endurance in older adults. J Aging Phys Act. 1998;6(4):363–75. doi: 10.1123/japa.6.4.363.
28. Rikli RE, Jones CJ. Development and validation of a functional fitness test for community-residing older adults. J Aging Phys Act. 1999;7(2):129–61. doi: 10.1123/JAPA.7.2.129.
29. Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validation of the fatigue severity scale in a Swiss cohort. Sleep. 2008;31(11):1601–7. doi: 10.1093/sleep/31.11.1601, PMID: 19014080.
30. Liu Z, Kuo P-L, Horvath S, Crimmins E, Ferrucci L, Levine M. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study. PLoS Med. 2018;15(12):e1002718. doi: 10.1371/journal.pmed.1002718, PMID: 30596641.
31. Syddall HE, Martin HJ, Harwood RH, Cooper C, Sayer AA. The SF-36: a simple, effective measure of mobility-disability for epidemiological studies. J Nutr Health Aging. 2009;13(1):57–62. doi: 10.1007/s12603-009-0010-4.
32. Brazier JE, Harper R, Jones N, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160–4. doi: 10.1136/bmj.305.6846.160, PMID: 1285753.
33. Bruce RA. Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation. Ann Clin Res. 1971;3(6):323–32. PMID: 5156892.
34. Borson S, Scanlan JM, Chen P, Ganguli M. The Mini‐Cog as a screen for dementia: validation in a population‐based sample. J Am Geriatr Soc. 2003;51(10):1451–4. doi: 10.1046/j.1532-5415.2003.51465.x, PMID: 14511167.
35. US Department of Health Human Services. Common terminology criteria for adverse events (CTCAE) version 5.0. In: National Institutes of Health, editor. National Institutes of Health, National Cancer Institute. Bethesda, USA: National Institutes of Health; 2017.
36. Khan SS, Singer BD, Vaughan DE. Molecular and physiological manifestations and measurement of aging in humans. Aging cell. 2017;16(4):624–33. doi: 10.1111/acel.12601, PMID: 28544158.
37. Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012;7(7):e42357. doi: 10.1371/journal.pone.0042357, PMID: 22848760.
38. Fisher RA. On the" probable error" of a coefficient of correlation deduced from a small sample. Metron. 1921;1:3–32.
39. Hopewell S, Chan A-W, Collins GS, Hróbjartsson A, Moher D, Schulz KF, et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. The Lancet. 2025;405(10489):1633–40. doi: 10.1016/S0140-6736(25)00672-5.
40. Clement J, Wong M, Poljak A, Sachdev P, Braidy N. The Plasma NAD+ Metabolome Is Dysregulated in “Normal” Aging. Rejuv Res. 2018;22(2):121–30. doi: 10.1089/rej.2018.2077, PMID: 30124109.
41. Pencina KM, Valderrabano R, Wipper B, Orkaby AR, Reid KF, Storer T, et al. Nicotinamide adenine dinucleotide augmentation in overweight or obese middle-aged and older adults: A physiologic study. J Clin Endocrinol Metab. 2023;108(8):1968–80. doi: 10.1210/clinem/dgad027.
42. Li BS, Zhu RZ, Lim S-H, Seo JH, Choi B-M. Apigenin alleviates oxidative stress-induced cellular senescence via modulation of the SIRT1-NAD+-CD38 Axis. Am J Chin Med. 2021;49(05):1235–50. doi: 10.1142/S0192415X21500592.
43. Yazdanyar A, Aziz MM, Enright PL, Edmundowicz D, Boudreau R, Sutton-Tyrell K, et al. Association between 6-minute walk test and all-cause mortality, coronary heart disease–specific mortality, and incident coronary heart disease. J Aging Health. 2014;26(4):583–99. doi: 10.1177/0898264314525665, PMID: 24695552.
44. Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999;70(2):113–9. doi: 10.1080/02701367.1999.10608028, PMID: 10380242.
45. Mhaske MM, Devi T P, Jagtap VK. Comparison of the effectiveness of visual imagery technique and progressive relaxation technique on anxiety and depression in subjects with moderate chronic obstructive pulmonary disease. Asian J Pharm Clin Res. 2018;11(6):318–23. doi: 10.22159/ajpcr.2018.v11i6.25067.
46. Sari RK, Sutiadiningsih A, Zaini H, Meisarah F, Hubur A. Factors affecting cognitive intelligence theory. J Crit Rev. 2020;7(17):402–10. doi: 10.31838/jcr.07.17.56.
47. Thakur T, Singh AP, Singh AP. A review on herbal plants with skeletal muscle relaxant activity. Int J Curr Pharm Res. 2025;17(4):10–4. doi: 10.22159/ijcpr.2025v17i4.7005.
48. Luan G, Wang Y, Wang Z, Zhou W, Hu N, Li G, et al. Flavonoid glycosides from fenugreek seeds regulate glycolipid metabolism by improving mitochondrial function in 3T3-L1 adipocytes in vitro. J Agric Food Chem. 2018;66(12):3169–78. doi: 10.1021/acs.jafc.8b00179.
49. Yuan Y, Liang B, Liu X-L, Liu W-J, Huang B-H, Yang S-B, et al. Targeting NAD+: is it a common strategy to delay heart aging? Cell Death Discov. 2022;8(1):230. doi: 10.1038/s41420-022-01031-3, PMID: 35474295.
50. Ruiz-Meana M, Bou-Teen D, Ferdinandy P, Gyongyosi M, Pesce M, Perrino C, et al. Cardiomyocyte ageing and cardioprotection: consensus document from the ESC working groups cell biology of the heart and myocardial function. Cardiovasc Res. 2020;116(11):1835–49. doi: 10.1093/cvr/cvaa132, PMID: 32384145.
51. Almatroodi SA, Almatroudi A, Alsahli MA, Rahmani AH. Fenugreek (Trigonella foenum-graecum) and its active compounds: a review of its effects on human health through modulating biological activities. Pharmacogn J. 2021;13(3):813–21. doi: 10.5530/pj.2021.13.103.
52. Sun M, Ding Q. Correlation of dietary flavonoid intake with chronic bronchitis, emphysema, and asthma in U.S. adults: A large, national, cross-sectional study. PLoS One. 2024;19(10):e0309310. doi: 10.1371/journal.pone.0309310, PMID: 39432452.
53. Zhu X-H, Lu M, Lee B-Y, Ugurbil K, Chen W. In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences. Proc Natl Acad Sci U S A. 2015;112(9):2876–81. doi: 10.1073/pnas.1417921112, PMID: 25730862.
54. Salam SGA, Rashed MM, Ibrahim NA, Rahim EAA, Aly TA, Al-Farga A. Phytochemical screening and in-vitro biological properties of unprocessed and household processed fenugreek (Trigonella foenum-graecum Linn.) seeds and leaves. Sci Rep. 2023;13(1):7032. doi: 10.1038/s41598-023-31888-y, PMID: 37120447.
55. Eaknai W, Bunwatcharaphansakun P, Phungbun C, Jantimaporn A, Chaisri S, Boonrungsiman S, et al. Ethanolic fenugreek extract: Its molecular mechanisms against skin aging and the enhanced functions by nanoencapsulation. Pharmaceuticals. 2022;15(2):254. doi: 10.3390/ph15020254, PMID: 35215366.
56. Liu L, Su X, Quinn WJ, III, Hui S, Krukenberg K, Frederick DW, et al. Quantitative Analysis of NAD Synthesis-Breakdown Fluxes. Cell Metab. 2018;27(5):1067–80. doi: 10.1016/j.cmet.2018.03.018.
57. Lopez J, Perez-Rojo G, Noriega C, Sánchez-Cabaco A, Sitges E, Bonete B. Quality-of-life in older adults: its association with emotional distress and psychological wellbeing. BMC Geriatr. 2024;24(1):815. doi: 10.1186/s12877-024-05401-7, PMID: 39385087.
58. Hausenblas HA, Conway KL, Coyle KRM, Barton E, Smith LD, Esposito M, et al. Efficacy of fenugreek seed extract on men's psychological and physical health: a randomized placebo-controlled double-blind clinical trial. J Complement Integr Med. 2020;18(2):445–8. doi: 10.1515/jcim-2019-0101, PMID: 32441668.
59. Foroumandi E, Javan R, Moayed L, Fahimi H, Kheirabadi F, Neamatshahi M, et al. The effects of fenugreek seed extract supplementation in patients with Alzheimer's disease: A randomized, double-blind, placebo-controlled trial. Phytother Res. 2023;37(1):285–94. doi: 10.1002/ptr.7612.
60. Yoshino J, Mills KF, Yoon MJ, Imai Si. Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- And Age-Induced Diabetes in Mice. Cell Metab. 2011;14(4):528–36. doi: 10.1016/j.cmet.2011.08.014.
61. Yoshino J, Baur JA, Imai Si. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metab. 2018;27(3):513–28. doi: 10.1016/j.cmet.2017.11.002.
62. Wilborn C, Hayward S, Taylor L, Urbina S, Foster C, Deshpande P, et al. Effects of a Proprietary Blend Rich in Glycoside Based Standardized Fenugreek Seed Extract (Ibpr) on Inflammatory Markers During Acute Eccentric Resistance Exercise in Young Subjects. Asian J Pharm Clin Res. 2017;10(10):99. doi: 10.22159/ajpcr.2017.v10i10.18811.
63. Nacarelli T, Lau L, Fukumoto T, Zundell JA, Fatkhutdinov N, Wu S, et al. NAD+ Metabolism Governs the Proinflammatory Senescence-Associated Secretome. Nat Cell Biol. 2019;21(3):397–407. doi: 10.1038/s41556-019-0287-4.
Published
How to Cite
Issue
Section
Copyright (c) 2026 Prasad A Thakurdesai, Pallavi Deshpande, Namrata Desai, Dhananjay Raje
This work is licensed under a Creative Commons Attribution 4.0 International License.